Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
Biomarker
|
disease |
BEFREE |
Mutation analysis of the SCN1B, SCN1A and GABRG2 genes in children affected by Genetic (Generalised) Epilepsy with Febrile Seizures plus (GEFS(+)) and their affected and some unaffected family members, coming from a restricted geographic area, was performed.
|
22011963 |
2012 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCN1A, the gene encoding the brain voltage-gated sodium channel alpha(1) subunit (Na(V)1.1), are associated with genetic forms of epilepsy, including generalized epilepsy with febrile seizures plus (GEFS+ type 2), severe myoclonic epilepsy of infancy (SMEI) and related conditions.
|
16210358 |
2005 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Here, we provide the first report of clinical presentation and mutational analysis of SCN1A gene in 36 Malaysian GEFS+ patients.
|
22944210 |
2012 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Generalized epilepsy with febrile seizures plus (GEFS+) is an autosomal dominant condition often caused by mutations in SCN1A that usually first manifests as childhood simple febrile seizures but may progress to a variety of afebrile generalized seizure types.
|
28262406 |
2017 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Causative variants in SCN1A gene which codes the main, pore-forming subunit of the channel expressed in central nervous system are associated predominantly with Dravet syndrome (DS), as well as with generalized epilepsy with febrile seizures plus (GEFS+) making it one of the most significant epilepsy gene.
|
27045673 |
2016 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the voltage-gated sodium channel subunit gene SCN1A have been associated with febrile seizures (FSs) in autosomal dominant generalized epilepsy with febrile seizures plus (GEFS+) families and severe myoclonic epilepsy of infancy.
|
12027919 |
2002 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the alpha-subunit of the first neuronal sodium channel gene SCN1A have been described in isolated patients with severe myoclonic epilepsy in infancy or Dravet syndrome and in families with generalized epilepsy with febrile seizures plus.
|
15087100 |
2004 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SCN1A gene have been identified in a variety of epilepsy phenotypes, from severe encephalopathies such as Dravet syndrome to milder familial forms such as generalized epilepsy with febrile seizures plus.
|
19782004 |
2009 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCN1A and SCN2A are responsible for several dominant idiopathic epilepsy disorders, including generalized epilepsy with febrile seizures plus (GEFS+) and severe myoclonic epilepsy of infancy (SMEI).
|
17881658 |
2007 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCN1A, the gene encoding the alpha1 subunit of the sodium channel, have been found in severe myoclonic epilepsy of infancy (SMEI) and generalized epilepsy with febrile seizures plus (GEFS+).
|
14504318 |
2003 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the NaV1.1 neuronal sodium channel alpha-subunit (SCN1A) gene have been documented in a spectrum of epilepsy syndromes, ranging from the relatively benign generalized epilepsy with febrile seizures plus (GEFS(+)) to severe myoclonic epilepsy in infancy (SMEI), and rare cases of familial migraine.
|
19469841 |
2009 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the three genes SCN1A, SCN1B and GABRG2, all encoding subunits of ion channels, have been known to cause generalized epilepsy with febrile seizures plus (GEFS+) in families of different origin.
|
17927801 |
2008 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Missense mutations in the voltage-gated sodium channel a1 subunit gene (SCN1A) were firstly identified in patients with generalized epilepsy with febrile seizures plus additional symptoms (GEFS + ).
|
17129991 |
2006 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
There was a significant phenotype-genotype relationship in generalized epilepsy with febrile seizures plus and severe myoclonic epilepsy of infancy with SCN1A missense mutations.
|
15277629 |
2004 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Genetic defects in the coding sequence lead to generalized epilepsy with febrile seizures plus (GEFS+) and a range of childhood epileptic encephalopathies of varied severity (e.g., SMEI).All published mutations are collated.
|
15880351 |
2005 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Generalized epilepsy with febrile seizures plus (GEFS+) and severe myoclonic epilepsy in infancy (SMEI) are associated with sodium channel α-subunit type-1 gene (SCN1A) mutations.
|
20550552 |
2010 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCN1A, the gene encoding the brain voltage-gated sodium channel alpha(1) subunit (Na(V)1.1), are associated with at least two forms of epilepsy, generalized epilepsy with febrile seizures plus and severe myoclonic epilepsy of infancy (SMEI).
|
15263074 |
2004 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations.
|
14738422 |
2004 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Recent studies provided evidence that mutations in SCN1A represent the most frequent cause of generalized epilepsy with febrile seizures plus an autosomal-dominant epilepsy syndrome.
|
12742596 |
2003 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCN1A have been reported in patients with different types of epilepsy, including generalized epilepsy with febrile seizures plus, severe myoclonic epilepsy in infancy, malignant migrating partial seizures in infancy, and other infantile epileptic encephalopathies.
|
27889818 |
2017 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The majority of mutations (>100) associated with generalized epilepsy with febrile seizures plus (GEFS+) and severe myoclonic epilepsy of infancy (SMEI) occur in SCN1A encoding the NaV1.1 neuronal sodium channel alpha-subunit.
|
16380441 |
2006 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
A novel inherited mutation in the voltage sensor region of SCN1A is associated with Panayiotopoulos syndrome in siblings and generalized epilepsy with febrile seizures plus.
|
19339291 |
2009 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Different SCN1A mutations are known to cause a variety of phenotypes, such as generalized epilepsy with febrile seizures plus (GEFS+), Dravet syndrome and familial hemiplegic migraine (FHM).
|
19673951 |
2009 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We identified seven cases with non-EE GEFS+ phenotypes and de novo SCN1A pathogenic variants, including a monozygotic twin pair.
|
28084635 |
2017 |
Generalized Epilepsy with Febrile Seizures Plus
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We report on two patients with SCN1A mutations and severe epilepsy within the spectrum of generalized epilepsy with febrile seizures plus syndrome (GEFS+), the phenotypes being consistent with DS and MAE, respectively.
|
21396429 |
2011 |